Concerns About Antidepressants and Pregnancy

Dr. Adam Urath, a specialist in fetal and maternal medicine, has raised significant concerns regarding the informed consent given to women prescribed antidepressants during pregnancy. His focus is particularly on selective serotonin reuptake inhibitors (SSRIs).

“Right now, I’m closely monitoring the use of antidepressants in pregnant women because it’s quite common,” Urath shared during a conversation with Ally Beth Stucky.

He emphasized the fact that these medications are not natural. “They’re chemicals created in labs, not things like oranges growing on trees,” he explained.

Urath noted that these drugs can transfer from mother to fetus, impacting serotonin receptors which are crucial for fetal development. “When you have this complex system that relies on serotonin and then introduce these chemicals, it clouds the delicate balance needed,” he continued.

While these medications can help with mental health, Urath pointed out, they also have far-reaching effects on the body. For instance, research shows that women taking SSRIs have an increased risk of bleeding due to their effect on platelet function.

He also highlighted additional health implications such as weakened bones and higher rates of osteoporosis in women on these medications. This is concerning, he says, because early pregnancy loss is becoming more frequent, and the rates of birth defects and preterm births are on the rise.

“We’ve seen increases in issues like miscarriages and various birth defects,” Urath elaborated. “Also, the number of low birth weight babies is climbing, as is the condition known as preeclampsia, which causes high blood pressure and other complications.”

“Postpartum bleeding remains a significant issue, too,” he added, pointing out that this can lead to severe consequences for maternal health.